Opening the UCLA Fielding School of Public Health's newest research center, dedicated to the mission of improving the health and social well-being of sexual and gender minorities, would be a challenging task at any time. For Dr.
“Flurona” isn’t a new COVID-19 variant. Nor is it a new disease or any kind of medical term.
The word flurona has gained popularity as a way to describe the condition of testing positive for both COVID-19 and the flu at the same time. As flu season picks up in the U.S. and in other countries, some hospitals and COVID-19 testing sites in California and Texas in the U.S., and overseas in Israel are reporting instances of people having both influenza and COVID-19.
The omicron variant provides clues about COVID-19’s trajectory
Though omicron is infecting a record number of people around the world, for those who’ve been vaccinated against COVID-19 and received a booster shot, a bout with the variant is likely to feel like an ordinary cold.
This could be a promising development in the pandemic’s trajectory.
Ryan Tripp is caught in a nightmare.
Like it was for most athletes, 2020 was rough for Tripp, now a junior playing basketball at Los Angeles Dorsey High. Stuck in the house as COVID-19 wiped out any hope for a season. Unable to so much as hoop at the local park.
When the Los Angeles Unified School District announced games would be postponed this week as the Omicron variant continues to surge, worry started to creep in again for Tripp. Worry that the break wouldn’t just stop at a week — that 2022 would be 2020, Part Two.
When Dr. Robert Kim-Farley heard that COVID-19 had reached the United States, on Jan. 20, 2020, he immediately recalled the grim images from China that he had been seeing online, with people dying in the streets outside of overwhelmed hospitals.
After a frenetic few weeks when the Omicron variant of the coronavirus seemed to infect everyone, including the vaccinated and boosted, the United States is finally seeing encouraging signs.
As cases decline in some parts of the country, many have begun to hope that this surge is the last big battle with the virus — that because of its unique characteristics, the Omicron variant will usher Americans out of the pandemic.
More than 100,000 Americans died from diabetes in 2021, marking the second consecutive year for that grim milestone and spurring a call for a federal mobilization similar to the fight against HIV/AIDS.
On the cusp of the third year of the COVID-19 pandemic, the United States is battling back the biggest surge of the virus yet with the omicron variant.
Cases, even while receding in some places, are near record levels. And daily deaths, while lower than the peak of last winter, are still averaging more than 2,000 nationwide.
Despite pitched battles over masks and vaccines, life appears somewhat normal in many respects -- kids are going to school, people are going into work and large indoor gatherings and events are being held.
CNN interviewed Dr. Anne Rimoin, UCLA Fielding School of Public Health professor of epidemiology and the Gordon-Levin Endowed Chair in Infectious Diseases and Public Health, about the new strain of the Omicron variant called BA.2.
People who reported always wearing face masks or respirators, such as N95 masks, in public indoor settings were significantly less likely to later test positive for the coronavirus than people who said they never wore masks in such places, researchers at the California Department of Public Health reported Friday.
The study, a phone survey conducted before omicron became the dominant variant in the United States, also suggested that surgical masks and N95 or KN95 respirators provided better protection than cloth masks.